|
|
Incorporated in 2000, Thyrocare Technologie Ltd is one of the leading pan-India diagnostic chains and conduct an array of medical diagnostic tests and profiles of tests that helps in early detection and management of disorders and diseases.
They are India's first fully automated diagnostic laboratory having its strong presence in more than 2000 cities / towns in India and internationally. As of November 30, 2015, they offered 192 tests and 54 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
Their laboratory process over 30,000 sample and above 1 lakh investigations every day. Their profiles of tests include 17 profiles of tests administered under their 'Aarogyam' brand. Through wholly owned subsidiary, NHL, they operate a network of molecular imaging centers in New Delhi, Navi Mumbai and Hyderabad, focused on early and effective cancer monitoring.
|
Particulars |
For the year/period ended (in Rs. Million) | |
| 31-Dec-15 | 31-Mar-15 | |
| Total Revenue | 1,804.73 | 1,903.38 |
| Profit After Tax (PAT) | 400.21 | 432.54 |
The object of the issue are to:
1. Achieve the benefits of listing the Equity Shares on the BSE and the NSE; and
2. Carry out the sale of up to 10,744,708 Equity Shares by the Selling Shareholders.
| Thyrocare Technologies IPO Date | Apr 27, 2016 to Apr 29, 2016 |
| Thyrocare Technologies IPO Face Value | ₹10 per share |
| Thyrocare Technologies IPO Price | ₹420 to ₹446 per share |
| Thyrocare Technologies IPO Lot Size | 33 Shares |
| Issue Size | 10,744,708 shares of ₹10 (aggregating up to ₹479.21 Cr) |
| Offer for Sale | 10,744,708 shares of ₹10 (aggregating up to ₹[.] Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Company Promoters | The promoters of the company are: 1. Dr A. Velumani |
The Thyrocare Technologies IPO lot size is 33 shares. A retail-individual investor can apply for up to 13 lots (429 shares or ₹191,334).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,718 |
| Retail (Max) | 13 | 429 | ₹191,334 |
Considering the brand image and the operational methods, the company is poised for bright prospects ahead. Investment in this IPO will bring reasonable rewards in coming years. Investment may be considered for short to long term.
Read detail review...The Thyrocare Technologies IPO is subscribed 73.55 times on Apr 29, 2016 11:15:00 PM. The public issue subscribed 8.73 times in the retail category, 73.18 times in the QIB category, and 225.30 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 73.18 |
| NII | 225.30 |
| Retail | 8.73 |
| Total | 73.55 |
| Listing Date | Monday, May 9, 2016 |
| BSE Script Code | 539871 |
| NSE Symbol | THYROCARE |
| Listing In | B Group of Securities |
| ISIN | INE594H01019 |
| IPO Price | ₹446 per share |
| Face Value | ₹10 per share |
|
|
|
Thyrocare Technologies Ltd
D/37-1, TTC Industrial Area
MIDC Turbhe,
Navi Mumbai 400 703
Phone: +(91 22) 2762 2762
Email: ramjee.d@thyrocare.com
Website: http://www.thyrocare.com
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: ttl.ipo@linkintime.co.in
Website: https://linkintime.co.in/
| Review By | Subscribe | Neutral | Avoid |
|---|---|---|---|
| Brokers | 7 | 0 | 0 |
| Members | 0 | 0 | 0 |
IPO Broker Recommendations
Thyrocare Technologies IPO is a main-board IPO of 10,744,708 equity shares of the face value of ₹10 aggregating up to ₹479.21 Crores. The issue is priced at ₹420 to ₹446 per share. The minimum order quantity is 33 Shares.
The IPO opens on Apr 27, 2016, and closes on Apr 29, 2016.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Thyrocare Technologies IPO opens on Apr 27, 2016 and closes on Apr 29, 2016.
Thyrocare Technologies IPO lot size is 33 Shares and the minimum order quantity is .
You can apply in Thyrocare Technologies IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Thyrocare Technologies IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Thyrocare Technologies IPO allotment status.
IPO Guru (4000+ Posts, 4600+ Likes)
Useful Articles
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
Top Contributor (200+ Posts)
IPO Mentor (700+ Posts, 100+ Likes)
